Fisher Biopharma Services (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.17 Cr
as on 13-12-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 63.78%
(FY 2022)
- Profit 72.00%
(FY 2022)
- Ebitda 47.77%
(FY 2022)
- Net Worth 20.28%
(FY 2022)
- Total Assets 22.59%
(FY 2022)
About Fisher Biopharma Services (India)
The Corporate was formerly known as Fisher Scientific (India) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjaykumar Patel and Tej Bazaz serve as directors at the Company.
- CIN/LLPIN
U73100GJ2006PTC047438
- Company No.
047438
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2006
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fisher Biopharma Services (India) Private Limited offer?
Fisher Biopharma Services (India) Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Transport Agents & Bulk Carriers, Goods Transport Services, Sourcing Services, Business Planning and Management, Business Consultant, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Fisher Biopharma Services (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjaykumar Patel  | Director | 01-Jun-2021 | Current |
| Tej Bazaz | Director | 01-Jun-2021 | Current |
Financial Performance of Fisher Biopharma Services (India).
Fisher Biopharma Services (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 63.78% increase. The company also saw a substantial improvement in profitability, with a 72% increase in profit. The company's net worth Soared by an impressive increase of 20.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fisher Biopharma Services (India)?
In 2022, Fisher Biopharma Services (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fisher Biopharma Services (India)?
Fisher Biopharma Services (India) has a workforce of 72 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fisher Biopharma Services (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fisher Biopharma Services (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
